Catalyst Wire Dossier Catalyst Wire Dossier

Osanetant

Osanetant · Acer Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Osanetant, covering 2024-08-07 to 2024-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause [Phase 1, Phase 2]

See pricing